Showing 2921-2930 of 7412 results for "".
- NPF Welcomes Four New Board Membershttps://practicaldermatology.com/news/npf-welcomes-four-new-board-members/2461907/The National Psoriasis Foundation (NPF) is adding four new members to the NPF Board of Directors. Andrew Blauvelt, MD, MBA, Valerie Harrison, PhD, Brian Janssen, and Diana Sandler, MD. will serve two-year terms effective July 1, 2023. Dr. Blauvelt will also serve as the Chair
- Abeona Therapeutics Submits Briefing Package for Pre-BLA Meeting with FDA in August 2023https://practicaldermatology.com/news/abeona-therapeutics-submits-briefing-package-for-pre-bla-meeting-with-fda-in-august-2023/2461901/Abeona Therapeutics Inc. completed the submission of the briefing package to the U.S. Food and Drug Administration (FDA) for the Company’s pre-Biologics License Application (BLA) meeting in August 2023. The purpose of the meeting is to discuss the format, content, and accept
- US FDA Grants Breakthrough Device Designation to Marpe's Dermatology Screening Systemhttps://practicaldermatology.com/news/us-fda-grants-breakthrough-device-designation-to-marpes-dermatology-screening-system/2461900/The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Marpe Technologies full-body Dermatology Screening System. The Marpe System is designed to acquire and analyze total body images to support the identification of malignant and pre-malignant lesions,
- Reinforcement Learning Model May Boost AI Skin Cancer Diagnosis Accuracyhttps://practicaldermatology.com/news/reinforcement-learning-model-may-boost-ai-skin-cancer-diagnosis-accuracy/2461897/Artificial intelligence (AI) is already being used to diagnose skin cancer, but so far, it can’t keep pace with the complex decision-making of doctors in practice. Now, an international research team is developing a learning method in which greater accuracy in AI results can be a
- More Screening Won’t Solve Racial Disparities in Melanoma Outcomeshttps://practicaldermatology.com/news/more-screening-wont-solve-racial-disparities-in-melanoma-outcomes/2461894/Increased skin cancer screening in individuals with skin of color is not sufficient to address racial disparities in melanoma survival rates, according to a new study in JAMA Dermatology.
- Merck, Moderna Initiate Phase 3 Study of V940-KEYTRUDA Combo for Adjuvant Treatment of Resected High-risk Melanomahttps://practicaldermatology.com/news/merck-moderna-initiate-phase-3-study-of-v940-mrna-4157-in-combination-with-keytruda-for-adjuvant-treatment-of-patients-with-resected-high-risk-melanoma/2461890/Merck today announced th
- Research Validates Atopic March Patternhttps://practicaldermatology.com/news/research-validates-the-atopic-march/2461889/New research validates a population-level pattern of the “allergic march” in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies. The average peak age of onset was approximately four months for eczema, 13 months
- Network Meta-analysis: Oral Isotretinoin Is the Most Effective Acne Treatmenthttps://practicaldermatology.com/news/network-meta-analysis-oral-isotretinoin-is-the-most-effective-acne-treatment/2461888/Oral isotretinoin, followed by topical antibiotic, benzoyl peroxide and retinoid, are most effective acne treatments, according to a network meta-analysis of 221 randomized controlled trials. For the study, researchers investigated the effectiveness of various pharmacological
- FDA Approves Verrica Pharmaceuticals’ YCANTH for Molluscum Contagiosumhttps://practicaldermatology.com/news/fda-approves-verrica-pharmaceuticals-ycanth-for-molluscum-contagiosum/2461882/The U.S. Food and Drug Administration (FDA) has given its nod to Verrica Pharmaceuticals Inc.’s YCANTH (cantharidin) topical solution for the treatment of molluscum contagiosum in adult and pediatric patients aged two and older. "It's the only topical FDA-approved therapy
- MRA Announces 2023 Dermatology Fellowship Award Recipientshttps://practicaldermatology.com/news/mra-announces-2023-dermatology-fellowship-award-recipients/2461878/The Melanoma Research Alliance (MRA) has announced its 2023 Dermatology Fellowship Award recipients. The awardees will each receive a $50,000 grant to support an independent research project focused on advancing melanoma prevention or detection. Along with critical finan